Johnson & Johnson has announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2025. The dividend will be $1.30 per share on the company’s common stock. According to the company, this dividend is payable on December 9, 2025, to shareholders who are recorded as of the close of business on November 25, 2025. The ex-dividend date is also set for November 25, 2025.
Johnson & Johnson describes itself as having a strong focus on healthcare innovation and states that it aims to prevent, treat, and cure complex diseases while developing smarter and less invasive treatments. The company operates in both Innovative Medicine and MedTech sectors and says it is positioned to deliver new healthcare solutions across these areas. More information about Johnson & Johnson can be found at https://www.jnj.com/.